| 1 |
33485325 | The negative charge of the 343 site is essential for maintaining physiological functions of CXCR4. | 2021 Jan 23 |
2 |
| 2 |
34424706 | Preclinical Evaluation of [64Cu]NOTA-CP01 as a PET Imaging Agent for Metastatic Esophageal Squamous Cell Carcinoma. | 2021 Sep 6 |
3 |
| 3 |
34525929 | A Prognostic Nomogram for Predicting Overall Survival in Pediatric Wilms Tumor Based on an Autophagy-related Gene Signature. | 2021 Aug 26 |
1 |
| 4 |
28497977 | Effect of Amino Acid Substitutions Within the V3 Region of HIV-1 CRF01_AE on Interaction with CCR5-Coreceptor. | 2017 Sep |
1 |
| 5 |
25785610 | Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization. | 2015 |
1 |
| 6 |
26397724 | Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636). | 2015 Oct 22 |
3 |
| 7 |
24676404 | Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China. | 2014 |
1 |
| 8 |
25082513 | Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4). | 2014 Sep 1 |
2 |
| 9 |
25313689 | Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms. | 2014 |
1 |
| 10 |
23925152 | Arginine insertion and loss of N-linked glycosylation site in HIV-1 envelope V3 region confer CXCR4-tropism. | 2013 |
3 |
| 11 |
22352868 | Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres. | 2012 Mar 22 |
2 |
| 12 |
20937786 | Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4. | 2011 Jan |
1 |
| 13 |
19109200 | Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4. | 2009 Jan 1 |
1 |
| 14 |
19707686 | Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids. | 2009 Sep 21 |
5 |
| 15 |
17268153 | [Optimization of cancer immunotherapy by controlling immune cell trafficking and biodistribution]. | 2007 Feb |
1 |
| 16 |
15658852 | Stereoselective synthesis of [L-Arg-L/D-3-(2-naphthyl)alanine]-type (E)-alkene dipeptide isosteres and its application to the synthesis and biological evaluation of pseudopeptide analogues of the CXCR4 antagonist FC131. | 2005 Jan 27 |
1 |
| 17 |
16141513 | Cell delivery system: a novel strategy to improve the efficacy of cancer immunotherapy by manipulation of immune cell trafficking and biodistribution. | 2005 Sep |
1 |
| 18 |
11287558 | Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo. | 2001 May |
1 |
| 19 |
10791873 | Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection. | 2000 May 1 |
1 |
| 20 |
11063591 | Structure-function study and anti-HIV activity of synthetic peptide analogues derived from viral chemokine vMIP-II. | 2000 Nov 7 |
1 |
| 21 |
11118068 | Interaction between HIV type 1 glycoprotein 120 and CXCR4 coreceptor involves a highly conserved arginine residue in hypervariable region 3. | 2000 Nov 20 |
3 |
| 22 |
10364300 | Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism. | 1999 Jul |
1 |
| 23 |
9730240 | Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection. | 1998 Jul |
1 |